Author / Remy Martin

eXmoor pharma completes $35 million Series A to expand cell and gene therapy manufacturing capabilities New GMP facility to complete eXmoor’s transition from consultancy to one-stop global cell and gene therapy partner Bristol, UK, May 30, 2023 – eXmoor pharma, the end-to-end cell and gene therapy (CGT) manufacturing partner, today announced the close of a…

eXmoor pharma and vaccine developer Imophoron sign process development partnership Multi-phase partnership will aim to manufacture vaccines for clinical use in eXmoor’s new facility to be launched in Q3, 2023 Bristol, UK, February 22, 2023 – eXmoor pharma, the cell and gene therapy partner specializing in accelerating the manufacturing journey from research to patients and…

eXmoor to present at OBN BioTuesday: 'A Spotlight on the Latest Research and Innovation In Cell & Gene Therapy' - 21 February eXmoor are delighted to participate in OBN's upcoming  BioTuesday event on 21 February, spotlighting 'Latest Research and Innovation In Cell & Gene Therapy'. During the evening, we will hear from some key thought…